National Health (Immunisation Program – Designated Vaccines) Variation Determination 2016 (No. 2) (Cth)

National Health (Immunisation Program – Designated Vaccines) Variation Determination 2016 (No. 2)

National Health Act 1953

I, Masha Somi, Delegate of the Minister for Health, make this Determination under subsections 9B (2) and (5) of the National Health Act 1953.

Dated   16 September 2016

Dr Masha Somi

Assistant Secretary

Immunisation Branch

Office of Health Protection

Department of Health

Delegate of the Minister for Health

1. Name of Determination

This Determination is the National Health (Immunisation Program – Designated Vaccines) Variation Determination 2016 (No. 2).

1. Commencement

Items 1 and 2 of the Schedule commence on the day after registration.

1. Authority

This Determination is made under subsections 9B (2) and (5) of the National Health Act 1953.       

1. Variation of National Health (Immunisation Program – Designated Vaccines) Determination 2014 (No. 1)

The Schedule varies the National Health (Immunisation Program – Designated     Vaccines) Determination 2014 (No. 1).

Schedule

[1] After subsection 7(8)

Insert new subsection

(8A)     For item 207C of Schedule 1, a designated vaccine mentioned in that item may be provided to:

(a)        a person who is at least 65 years;  or

(b)        an Aboriginal or Torres Strait Islander person who is aged at least 18 years; or

(c)        a person who is at least 18 years who:

(i)        has cardiac disease including cyanotic congenital heart disease, coronary artery disease and congestive heart failure;  or

(ii)       has a chronic respiratory condition including suppurative lung disease, bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease, chronic emphysema and severe asthma;  or

(iii)      has another chronic illness requiring regular medical follow-up or hospitalisation in the preceding year, including diabetes mellitus, chronic metabolic diseases, chronic renal failure, haemoglobinopathies and impaired immunity (including drug-induced immune impairment);  or

(iv)      has a chronic neurological condition, including multiple sclerosis, spinal cord injuries, seizure disorders or other neuromuscular disorders;  or

(v)       has impaired immunity, including HIV infection;  or

(vi)      is pregnant.

[2] After item 207B in Schedule 1, Part 2

Insert

207C Vaccine Influenza Circumstances Vaccine may be provided in the circumstances set out in subsection 7 (8A). Afluria Quad Injection (0.5mL) 1 dose per calendar year.